Yüklüyor......
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
SIMPLE SUMMARY: Several clinical protocols are exploring the anticancer effect of immunotherapy combined to targeted therapy. Indeed, emerging evidence demonstrates that small-molecule targeted inhibitors promote the antitumor immune response. In the case of mechanistic target of rapamycin (mTOR) in...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8002586/ https://ncbi.nlm.nih.gov/pubmed/33802831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061359 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|